MetaCap

Alignment Healthcare Inc. (ALHC)

NASDAQ: ALHCHealth CareMedical SpecialitiesUSD

6.37-0.13 (-2.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ALHC stock chart

Technical analysis

Key statistics

All statistics
52-week range
6.01 – 25.12
Day range
6.26 – 6.81
Volume / Avg
5.00M / 8.19M
Beta
—

52-week range

$6.01$25.12

ALHC stock today

On Nov 20, ALHC ended the session at $6.37, shedding $0.13 (2.00%), versus the S&P 500's 3.70% decline. At this level, ALHC sits near the bottom of its 52-week range of $6.01 to $25.12: 74.6% below the high, set on Jul 7, 2026 and 6.0% above the low. ALHC is down 67.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 61.9%.

At 45.5x trailing earnings, Alignment Healthcare trades above the peer-group median of 37.3x. Its forward P/E of 11.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Alignment Healthcare

Company profile

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans.

Industry
Medical Specialities
CEO
Mr. John E. Kao
Headquarters
Orange, CA
Employees
1,849
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, Alignment Healthcare generated $3.95 billion in revenue, up 46.1% from fiscal 2024, its 6th consecutive year of revenue growth. Alignment Healthcare reported a net loss of $724,000, compared with a loss of $128.0 million a year earlier. Operating margin was 0.4%.

Alignment Healthcare annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.95B$2.70B$1.82B$1.43B$1.17B
Growth+46.06%+48.25%+27.16%+22.81%+21.74%
Net income$-724.00K$-128.03M$-148.02M$-149.55M$-195.29M
EPS (diluted)$0.00$-0.67$-0.79$-0.83$-1.14

Analyst forecast

Forecast

Consensus (15 analysts)

buy

Avg. price target

$10.79+69.39%

  • Strong buy 3
  • Buy 6
  • Hold 6
  • Sell 0
  • Strong sell 0

Target range

Low $8.00High $17.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$-0.04 vs $-0.04

ALHC news

All ALHC news

Alignment Healthcare peers

Health Care sector
ALHC peer companies
CompanyPrice% ChgMarket capCompare
LMRILumexa Imaging Holdings Inc.14.26+1.42%$1.37Bvs ALHC
TRUPTrupanion Inc.35.56-0.86%$1.54Bvs ALHC
PSNLPersonalis Inc.14.27-3.06%$1.55Bvs ALHC
FRNMFreenome Inc.9.36-5.69%$1.04Bvs ALHC
CSTLCastle Biosciences Inc.32.86-1.63%$1.01Bvs ALHC
FTREFortrea Holdings Inc.18.55-7.94%$1.79Bvs ALHC
CLOVClover Health Investments Corp. Class A3.73-1.06%$2.00Bvs ALHC
VCYTVeracyte Inc.25.13+0.36%$2.03Bvs ALHC

Indexes, lists and sector

Alignment Healthcare stock FAQ

What is Alignment Healthcare's stock price today?

ALHC last traded at $6.37 as of Nov 20, 4:00 PM EST, down 2.00% on the day. Prices are delayed at least 15 minutes.

What is ALHC's P/E ratio?

ALHC trades at a trailing P/E ratio of 45.50 and a forward P/E of 11.48, compared with a median of 37.3 for its closest peers.

Who is Alignment Healthcare's CEO?

Mr. John E. Kao is the chief executive officer of Alignment Healthcare Inc., which has about 1,849 employees.

What is the ALHC 52-week high?

The 52-week high for ALHC is $25.12 and the 52-week low is $6.01. The stock is currently 74.6% below its high.

Compare ALHC